Literature DB >> 15029226

Insertional oncogenesis in gene therapy: how much of a risk?

M Sadelain1.   

Abstract

Mesh：

Year:  2004        PMID： 15029226     DOI： 10.1038/sj.gt.3302243

Source DB:  PubMed          Journal:  Gene Ther        ISSN： 0969-7128            Impact factor:   5.250


× No keyword cloud information.
  21 in total

1.  Tissue- and tumor-specific targeting of murine leukemia virus-based replication-competent retroviral vectors.

Authors:  Christian Metzl; Daniela Mischek; Brian Salmons; Walter H Günzburg; Matthias Renner; Daniel Portsmouth
Journal:  J Virol       Date:  2006-07       Impact factor: 5.103

Review 2.  Antibody-modified T cells: CARs take the front seat for hematologic malignancies.

Authors:  Marcela V Maus; Stephan A Grupp; David L Porter; Carl H June
Journal:  Blood       Date:  2014-02-27       Impact factor: 22.113

3.  Development of a Cell-Based Gene Therapy Approach to Selectively Turn Off Bone Formation.

Authors:  Pedro Alvarez-Urena; Banghe Zhu; Gabrielle Henslee; Corinne Sonnet; Eleanor Davis; Eva Sevick-Muraca; Alan Davis; Elizabeth Olmsted-Davis
Journal:  J Cell Biochem       Date:  2017-07-31       Impact factor: 4.429

4.  The Oncogenic Potential of Mesenchymal Stem Cells in the Treatment of Cancer: Directions for Future Research.

Authors:  Eric N Momin; Guillermo Vela; Hasan A Zaidi; Alfredo Quiñones-Hinojosa
Journal:  Curr Immunol Rev       Date:  2010-05-01

Review 5.  Cardiovascular gene therapy for myocardial infarction.

Authors:  Maria C Scimia; Anna M Gumpert; Walter J Koch
Journal:  Expert Opin Biol Ther       Date:  2013-12-16       Impact factor: 4.388

6.  Recombinase mediated cassette exchange into genomic targets using an adenovirus vector.

Authors:  David A Sorrell; Claire J Robinson; Jo-Ann Smith; Andreas F Kolb
Journal:  Nucleic Acids Res       Date:  2010-04-05       Impact factor: 16.971

7.  Erythroid-specific human factor IX delivery from in vivo selected hematopoietic stem cells following nonmyeloablative conditioning in hemophilia B mice.

Authors:  Alex H Chang; Matthias T Stephan; Leszek Lisowski; Michel Sadelain
Journal:  Mol Ther       Date:  2008-08-05       Impact factor: 11.454

Review 8.  Genetic therapies against HIV.

Authors:  John J Rossi; Carl H June; Donald B Kohn
Journal:  Nat Biotechnol       Date:  2007-12       Impact factor: 54.908

Review 9.  Making a Hematopoietic Stem Cell.

Authors:  Michael G Daniel; Carlos-Filipe Pereira; Ihor R Lemischka; Kateri A Moore
Journal:  Trends Cell Biol       Date:  2015-10-31       Impact factor: 20.808

10.  Adoptive transfer of genetically modified Wilms' tumor 1-specific T cells in a novel malignant skull base meningioma model.

Authors:  Kenichiro Iwami; Atsushi Natsume; Masasuke Ohno; Hiroaki Ikeda; Junichi Mineno; Ikuei Nukaya; Sachiko Okamoto; Hiroshi Fujiwara; Masaki Yasukawa; Hiroshi Shiku; Toshihiko Wakabayashi
Journal:  Neuro Oncol       Date:  2013-03-03       Impact factor: 12.300
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.